1. Home
  2. ALOT vs INKT Comparison

ALOT vs INKT Comparison

Compare ALOT & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALOT
  • INKT
  • Stock Information
  • Founded
  • ALOT 1969
  • INKT 2017
  • Country
  • ALOT United States
  • INKT United States
  • Employees
  • ALOT N/A
  • INKT N/A
  • Industry
  • ALOT Computer peripheral equipment
  • INKT Medicinal Chemicals and Botanical Products
  • Sector
  • ALOT Technology
  • INKT Health Care
  • Exchange
  • ALOT Nasdaq
  • INKT Nasdaq
  • Market Cap
  • ALOT 78.2M
  • INKT 69.2M
  • IPO Year
  • ALOT N/A
  • INKT 2021
  • Fundamental
  • Price
  • ALOT $9.04
  • INKT $13.22
  • Analyst Decision
  • ALOT
  • INKT Buy
  • Analyst Count
  • ALOT 0
  • INKT 3
  • Target Price
  • ALOT N/A
  • INKT $37.50
  • AVG Volume (30 Days)
  • ALOT 15.3K
  • INKT 25.0K
  • Earning Date
  • ALOT 12-11-2025
  • INKT 11-14-2025
  • Dividend Yield
  • ALOT N/A
  • INKT N/A
  • EPS Growth
  • ALOT N/A
  • INKT N/A
  • EPS
  • ALOT N/A
  • INKT N/A
  • Revenue
  • ALOT $151,593,000.00
  • INKT N/A
  • Revenue This Year
  • ALOT N/A
  • INKT N/A
  • Revenue Next Year
  • ALOT N/A
  • INKT N/A
  • P/E Ratio
  • ALOT N/A
  • INKT N/A
  • Revenue Growth
  • ALOT 0.63
  • INKT N/A
  • 52 Week Low
  • ALOT $7.53
  • INKT $4.56
  • 52 Week High
  • ALOT $17.24
  • INKT $76.00
  • Technical
  • Relative Strength Index (RSI)
  • ALOT 37.41
  • INKT 41.51
  • Support Level
  • ALOT $8.68
  • INKT $12.68
  • Resistance Level
  • ALOT $9.23
  • INKT $14.25
  • Average True Range (ATR)
  • ALOT 0.22
  • INKT 0.72
  • MACD
  • ALOT -0.02
  • INKT -0.13
  • Stochastic Oscillator
  • ALOT 30.74
  • INKT 20.09

About ALOT AstroNova Inc.

AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Test & Measurement (T&M). It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

Share on Social Networks: